IL-10-mediated suppression of TNF-α production is independent of its ability to inhibit NFκB activity

European Journal of Immunology

Volumn 28, Issue 5, 1998, Pages 1719-1726

  Clarke, Christopher J P ^a,b   Hales, Anne ^a   Hunt, Abigail ^a   Foxwell, Brian M J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

IL 10; IL 4; Macrophage; NF B; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 4; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL NUCLEUS; DNA; DNA-BINDING PROTEINS; I-KAPPA B PROTEINS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN BINDING; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031944393     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q     Document Type: Article

References (35)

1. Cassatella, M. A., Meda, L., Bonora, S., Ceska, M. and Constantin, G., Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 1993. 178: 2207-2211.
2. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 191993. 75: 263-274.
3. Berg, D. J., Kuhn, R., Rajewsky, K., Muller, W., Menon, S., Davidson, N., Grunig, G. and Rennick, D., Interleukin-10 is a central regulator of the response to LPS in murine models for endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995. 96: 2339-2347.
4. Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N. and Feldmann, M., Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 1996. 39: 495-503.
5. Rott, O., Fleischer, B. and Cash, E., Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994. 24: 1434 × 1440.
6. Bogdan, C., Paik, J., Vodovotz, Y. and Nathan, C., Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factorbeta and interleukin-10. J. Biol. Chem. 1992. 267: 23301-23308.
7. Takeshita, S., Gage, J. R., Kishimoto, T., Vredevoe, D. L. and Martinez Maza, O., Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J. Immunol. 1996. 156: 2591-2598.
8. Wang, P., Wu, P., Siegel, M. I., Egan, R. W. and Billah, M. M., IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 1994. 153: 811-816.
9. Wang, P., Wu, P., Siegel, M. I., Egan, R. W. and Billah, M. M., Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 1995. 270: 9558-9563.
10. Baldwin Jr., A. S., The NF-kappa-B and I-kappa-B proteins: New discoveries and insights. Annu. Rev. Immunol. 1996. 14: 649-681.
11. Gilmore, T. D. and Morin, P. J., The I kappa B proteins: members of a multifunctional family. Trends Genet. 1993. 9: 427-433.
12. Cogswell, J. P., Godlevski, M. M., Wisely, G. B., Clay, W. C., Leesnitzer, L. M., Ways, J. P. and Gray, J. G., NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J. Immunol. 1994. 153: 712-723.
13. Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A. and Jongeneel, C. V., Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med. 1990. 171: 35-47.
14. Mukaida, N., Mahe, Y. and Matsushima, K., Cooperative interaction of nuclear factor-kappa B-and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by proinflammatory cytokines. J. Biol. Chem. 1990. 265: 21128-21133.
15. Whelan, J., Ghersa, P., Hooft van Huijsduijnen, R., Gray, J., Chandra, C., Talabot, F. and DeLamarter, J. F., An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 1991. 19: 2645-2653.
16. Clarke, C. J., Taylor Fishwick, D. A., Hales, A., Chernajovsky, Y., Sugamura, K., Feldmann, M. and Foxwell, B. M., Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells. Eur J. Immunol, 1995. 25: 2961-2966.
17. Rooney, J. W., Emery, D. W. and Sibley, C. H., Slow response variant of the B lymphoma 70Z/3 defective in LPS activation of NF-kappa B. Immunogenetics 1990. 31: 65-72.
18. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben Neriah, Y. and Baeuerle, P. A., Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 1993. 365: 182-185.
19. Collart, M. A., Baeuerle, P. and Vassalli, P., Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 1990. 10: 1498-1506.
20. Donnelly, R. P., Crofford, L. J., Freeman, S. L., Buras, J., Remmers, E., Wilder, R. L. and Fenton, M. J., Tissue-spcific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J. Immunol. 1993. 151: 5603-5612.
21. Hart, P. H., Vitti, G. F., Burgess, D. R., Whitty, G. A., Piccoli, D. S. and Hamilton, J. A., Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 1989. 86: 3803-3807.
22. Mijatovic, T., Kruys, V., Caput, D., Defrance, P. and Huez, G., Interleukin-4 and -13 Inhibit Tumor Necrosis Factor-α mRNA Translational Activation in Lipopolysaccharide-induced Mouse Macophages. J. Biol. Chem. 1997. 272: 14394-14398.
23. Lee, J. C., Laydon, J. T., McDonnell, P. C et al., A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994. 372: 739-746.
24. Swantek, J., Cobb, M. and Geppert, T., Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysyccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/ SAPK. Mol. Cell. Biol. 1997. 17: 6274-6282.
25. Goldfeld, A. E., Strominger, J. L. and Doyle, C., Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines. J. Exp. Med. 1991. 174: 73-81.
26. Brown, C. Y., Lagnado, C. A., Vadas, M. A. and Goodall, G. J., Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J. Biol. Chem. 1996. 271: 20108-20112.
27. Mertz, P. M., DeWitt, D. L., Stetler Stevenson, W. G. and Wahl, L. M., Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 1994. 269: 21322-21329.
28. Palombella, V. J., Rando, O. J., Goldberg, A. L. and Maniatis, T., The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994. 78: 773-785.
29. Naumann, M. and Schleidereit, C., Activation of NF-kappa B in vivo is regulated by multiple phosphorylation. EMBO J. 1994. 13: 4597-4607.
30. Meyer, C. R, Wang, X., Chang, C., Templeton, D. and Tan, T. H., Interaction between c-Rel and the mitogen-activated protein kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J. Biol. Chem. 1996. 271: 8971-8976.
31. Ray, A. and Prefontaine, K. E., Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 1994. 91: 752-756.
32. Mattila, P. S., Ullman, K. S., Fiering, S., Emmel, E. A., McCutcheon, M., Crabtree, G. R. and Herzenberg, L. A., The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 1990. 9: 4425-4433.
33. Whiteside, S. T., Visvanathan, K. V. and Goodbourn, S., Identification of novel factors that bind to the RPD I region of the human beta-interferon promoter. Nucleic Acids Res. 1992. 20: 1531-1538.
34. Espevik, T. and Nissen Meyer, J., A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/ tumor necrosis factor from human monocytes. J. Immunol. Methods 1986. 95: 99-105.
35. Sambrook, J., Fritsch, E. F. and Maniatis, T. (Eds) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1989.